Search
At least two prior systemic therapies
go.drugbank.com/conditions/DBCOND0137602Drugs: Belumosudil · Copanlisib · Duvelisib · Epcoritamab · Glofitamab · Idecabtagene vicleucel +13 moreSynonyms: At least two prior systemic therapiesAtenolol
go.drugbank.com/drugs/DB00335ApprovedInvestigationalAtenolol is a cardioselective beta-blocker used in a variety of cardiovascular conditions. … [A235850,A235855] A Cochrane review of patients being treated for primary hypertension shows that atenolol shows a risk ratio of 0.88 for cardiovascular disease risk and a risk ratio of 0.99 for mortality
Mixtures: Aa-atenidone, Aa-atenidoneProducts: Ag-atenolol, Act AtenololAllantoin
go.drugbank.com/drugs/DB11100ApprovedInvestigationalAllantoin is a substance that is endogenous to the human body and also found as a normal component of human diets [FDA Label]. … More specifically, allantoin is a diureide of glyoxylic acid that is produced from uric acid. It is a major metabolic intermediate in most organisms.
Mixtures: Le Stick A Levres Onybel, Essential Solution Vita A Mask SheetProducts: ATOMU Essence A, AC Control SerumBimatoprost
go.drugbank.com/drugs/DB00905ApprovedInvestigationalBimatoprost, also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. … [L6910] It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug
Mixtures: BIMAPROS T, BEMATORİN-T 0,3 MG + 5 MG/1 ML GÖZ DAMLASI, ÇÖZELTİ, 1 ADETProducts: Ag-bimatoprost Rc, LUMIGAN 0.1MG/ML ATRLatanoprost
go.drugbank.com/drugs/DB00654ApprovedInvestigationalAnother benefit latanoprost is that it can be administered once a day.[A184490] … Latanoprost is a prodrug analog of prostaglandin F2 alpha that is used to treat elevated intraocular pressure (IOP). It was initially approved by the FDA in 1998.
Mixtures: LATANOPROST RATIO COMP AT, LATANOPROST RATIO COMP ATCategories: Compounds used in a research, industrial, or household settingTannic acid
go.drugbank.com/drugs/DB09372ApprovedInvestigationalTannic acid is a polyphenolic compound. It is a type of the commercially available tannins. It acts as a weak acid. … It is removed and used as medicine. In the old days it was used as antidote against different poisons.
Categories: Compounds used in a research, industrial, or household settingProducts: Zilactin Medicated Gel 7%Sertraline
go.drugbank.com/drugs/DB01104ApprovedInvestigationalSertraline is a popular antidepressant medication commonly known as a selective serotonin reuptake inhibitor (SSRI), and is similar to drugs such as [Citalopram] and [Fluoxetine].
Categories: Monoamine Oxidase A SubstratesProducts: Sertralin G.L. 50 mg - Filmtabletten, Sertralin G.L. 100 mg - FilmtablettenPolihexanide
go.drugbank.com/drugs/DB12277ApprovedInvestigational[A1351] It is effective against a wide range of Gram-positive and Gram-negative bacteria. … Polihexanide, also known as polyhexamethylene biguanide (PHMB), is a broad-spectrum antimicrobial polymer primarily used for topical antisepsis and wound management.
Categories: Compounds used in a research, industrial, or household settingProducts: Disposable Hand Antibacterial Gel, LeYiJie Alcohol Hand Wash Antibacterial GelIcosapent
go.drugbank.com/drugs/DB00159ApprovedInvestigationalNutraceuticalIt serves as the precursor for the prostaglandin-3 and thromboxane-3 families. … A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane
Mixtures: Ganilia Soft Gel, Protect Cardio AFProducts: GelSorafenib
go.drugbank.com/drugs/DB00398ApprovedInvestigationalSorafenib is a bi-aryl urea and an oral multikinase inhibitor. … It targets cell surface tyrosine kinase receptors and downstream intracellular kinases that are implicated in tumour cell proliferation and tumour angiogenesis.
Categories: UGT1A9 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates with a Narrow Therapeutic IndexProducts: Sorafenib G.L. 200 mg-Filmtabletten, Sorafenib G.L. 400 mg-Filmtabletten